Carfentanil Facts
Opioid;
Description
Carfentanil is a synthetic opioid of the anilidopiperidine class. It activates opioid receptors in the brain, suppressing pain signaling and depressing the drive to breathe.
Subjective effects include intense euphoria, pain suppression, heavy sedation, and a dissolving of anxiety. These effects are inferred entirely from opioid pharmacology — no controlled human data exist, and the onset-to-loss of consciousness window may be measured in seconds.
Dependence liability is high, and the estimated lethal dose of roughly 20 µg[1] leaves no margin between an active and a fatal dose. Standard naloxone often fails — carfentanil binds opioid receptors in ways that resist displacement,[2] its effects outlast naloxone by hours,[3] and blood concentrations in survivors and fatalities overlap.[4][5]
Dose and durationby route · individual sensitivity varies
No dose recorded for this route. The timings are not a dose guide.
Starts in 1 – 5 minLasts 4 – 10 hours
Body and dependence
- Acute toxicity
- Critical
- Chronic toxicity
- Critical
- Physical dependence
- High
- Psychological dependence
- High
- Withdrawal
- Severe · medical supervision
- Compulsive redosing
- High
Tolerance
- Builds
- Rapid
- Fully resets after
- 14 days
- Carries over to
- morphine;
fentanyl; heroin; oxycodone; hydromorphone; methadone
Effectslikely at a common dose
- Perception
- none likely · 5 possible, including Spatial disorientation, Visual acuity suppression, Visual haze / noise
- Body
- Bodily heaviness;
Body high; Breathing alteration; Constipation; Motor control impairment; Muscle relaxation; Pain suppression; Physical fatigue; Pupil constriction; Respiratory depression; Sedation; +12 possible, including Nausea, Abnormal heartbeat, Dizziness - Thinking
- Analysis suppression;
Cognitive fatigue; Cognitive impairment; Decision impairment; Focus suppression; Information processing suppression; Thought deceleration; +9 possible, including Memory suppression, Compulsive redosing urge, Confusion - Feeling
- Euphoria;
+4 possible, including Empathy suppression, Dysphoria - Self
- none likely · 6 possible, including Communication suppression, Craving, Social disconnection
- Time
- none likely · 2 possible, including Temporal disorientation
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
- Unresponsive / can't be woken, even to a firm sternal rub
- Slow, shallow, or stopped breathing
- Pinpoint pupils
- Blue/grey lips, fingertips, or skin (cyanosis)
- Limp body; pale, clammy skin
- Choking or gurgling sounds ("death rattle")
- Slow, erratic, or absent pulse
What to do
- Try to wake them — shout their name, firm sternal rub
- Call emergency services immediately
- Administer naloxone if available
- Give rescue breaths (or CPR if there is no pulse)
- Place them in the recovery position
- Stay with them; re-dose naloxone every 2–3 minutes if there is no response
- Reversal agent
- Naloxone (Narcan) — opioid antagonist. May require repeated doses; its effect can wear off before the opioid does.
With prompt naloxone and rescue breathing, reversal is usually rapid. Because naloxone can wear off before the opioid — especially with long-acting opioids (methadone) or high-potency ones (fentanyl) — a period of monitoring is needed even after the person revives.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]
- [2]^Endt F, Guo T, Steinritz D, Amend N, Gudermann T, Breit A (2025) Carfentanil stabilizes µ opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone — Archives of toxicology doi:10.1007/s00204-025-04048-6
- [3]^Mann J, Samieegohar M, Chaturbedi A, et al. (2022) Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest — Clinical pharmacology and therapeutics doi:10.1002/cpt.2696
- [4]^Kahl JH, Gonyea J, Humphrey SM, Hime GW, Boland DM (2018) Quantitative Analysis of Fentanyl and Six Fentanyl Analogs in Postmortem Specimens by UHPLC-MS-MS — Journal of analytical toxicology doi:10.1093/jat/bky054
- [5]^Wallage HR, Elliot M, Rajotte JW (2022) Carfentanil Blood Concentrations in Impaired Driving Investigations in Ontario, Canada — Journal of analytical toxicology doi:10.1093/jat/bkac039